- Filed
- May 23, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · May 21, 2024 | 1.15M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2024 | 1.15M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2024 | 567K sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 5.84K sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 2.92K sh |
| Dividends Paid | Q3 2024 · Mar 31, 2024 | $334.38K |
| Dividends Paid | Q3 2024 · Mar 31, 2023 | $601.88K |
| Operating Cash Flow | Q3 2024 · Mar 31, 2024 | −$5.55M |
| Operating Cash Flow | Q3 2024 · Mar 31, 2023 | −$11.53M |
| Long Term Debt | Q3 2024 · Mar 31, 2024 | $1.41M |
| Cash And Equivalents | Q3 2024 · Mar 31, 2024 | $957.11K |
| Cash And Equivalents | Q3 2024 · Jun 30, 2023 | $1.75M |
| Cash And Equivalents | Q3 2024 · Mar 31, 2023 | $1.88M |
| Cash And Equivalents | Q3 2024 · Jun 30, 2022 | $2.52M |
| Stockholders Equity | Q3 2024 · Mar 31, 2024 | −$19.57M |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | −$16.75M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $407.81K |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $4.8M |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | −$13.6M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | −$25.8M |
| Stockholders Equity | Q3 2024 · Sep 30, 2022 | −$16.08M |
| Stockholders Equity | Q3 2024 · Jun 30, 2022 | −$11.6M |
| Current Liabilities | Q3 2024 · Mar 31, 2024 | $9.8M |
| Current Liabilities | Q3 2024 · Jun 30, 2023 | $8.86M |
| Total Liabilities | Q3 2024 · Mar 31, 2024 | $12.22M |
| Total Liabilities | Q3 2024 · Jun 30, 2023 | $9.22M |
| Current Assets | Q3 2024 · Mar 31, 2024 | $1.98M |
| Current Assets | Q3 2024 · Jun 30, 2023 | $4.04M |
| Total Assets | Q3 2024 · Mar 31, 2024 | $4.64M |
| Total Assets | Q3 2024 · Jun 30, 2023 | $22.1M |
| Eps Diluted | Q3 2024 · Mar 31, 2024 | −$3.43 |
| Eps Diluted | Q3 2024 · Mar 31, 2024 | −$95.07 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | −$2,305.82 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | −$11,084.68 |
| Eps Basic | Q3 2024 · Mar 31, 2024 | −$3.43 |
| Eps Basic | Q3 2024 · Mar 31, 2024 | −$95.07 |
| Eps Basic restated | Q3 2024 · Mar 31, 2023 | −$2,305.82 |
| Eps Basic restated | Q3 2024 · Mar 31, 2023 | −$11,084.68 |
| Sga Expense | Q3 2024 · Mar 31, 2024 | $2.8M |
| Sga Expense | Q3 2024 · Mar 31, 2024 | $13.77M |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $7.37M |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $24.4M |
| Net Income | Q3 2024 · Mar 31, 2024 | −$2.84M |
| Net Income | Q3 2024 · Mar 31, 2024 | −$24.69M |
| Net Income | Q3 2024 · Dec 31, 2023 | −$17.05M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$4.8M |
| Net Income | Q3 2024 · Mar 31, 2023 | −$13.19M |
| Net Income | Q3 2024 · Mar 31, 2023 | −$31.5M |
| Net Income | Q3 2024 · Dec 31, 2022 | −$14.13M |
| Net Income | Q3 2024 · Sep 30, 2022 | −$4.17M |
| Operating Income | Q3 2024 · Mar 31, 2024 | −$1.81M |
| Operating Income | Q3 2024 · Mar 31, 2024 | −$23.36M |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$9.61M |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$37.17M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2024 | $474.7K |
| Cost Of Revenue | Q3 2024 · Mar 31, 2024 | $1.77M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $1.29M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $7.41M |
| Revenue | Q3 2024 · Mar 31, 2024 | $1.72M |
| Revenue | Q3 2024 · Mar 31, 2024 | $7M |
| Revenue | Q3 2024 · Mar 31, 2023 | $4.18M |
| Revenue | Q3 2024 · Mar 31, 2023 | $20.19M |
| Capex | Q3 2024 · Mar 31, 2023 | $3.32K |